Cresco Labs (CRLBF) Common Equity (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Common Equity came in at $244.2 million in Q1 2026, down 34.98% YoY from $375.6 million in Q1 2025, and down 3.28% on a QoQ basis from $252.5 million in Q4 2025.
Cresco Labs (CRLBF) Common Equity (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Common Equity data on file, last reported at $244.2 million in Q1 2026.
- Quarterly Common Equity fell 34.98% year-over-year to $244.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $244.2 million (down 34.98% YoY) and the FY2025 annual result came in at $252.5 million, down 34.95% from the prior year.
- Common Equity slipped to $244.2 million in Q1 2026, from $252.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $783.6 million in Q2 2022 to a low of $244.2 million in Q1 2026.
- A 5-year average of $470.4 million and a median of $420.0 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity climbed 8.31% — and 2023, when it slumped 44.8%.
- Tracing CRLBF's Common Equity over 5 years: stood at $587.7 million in 2022, then declined by 27.16% to $428.1 million in 2023, then retreated by 9.32% to $388.2 million in 2024, then plunged by 34.95% to $252.5 million in 2025, then retreated by 3.28% to $244.2 million in 2026.
- The last three Common Equity figures came in at $244.2 million (Q1 2026), $252.5 million (Q4 2025), and $340.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 4.05 Bn |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 263.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244.21 Mn |
| Dec 31, 2025 | 252.50 Mn |
| Sep 30, 2025 | 340.17 Mn |
| Jun 30, 2025 | 360.91 Mn |
| Mar 31, 2025 | 375.57 Mn |
| Dec 31, 2024 | 388.18 Mn |
| Sep 30, 2024 | 365.37 Mn |
| Jun 30, 2024 | 374.51 Mn |
| Mar 31, 2024 | 419.97 Mn |
| Dec 31, 2023 | 428.07 Mn |
| Sep 30, 2023 | 425.86 Mn |
| Jun 30, 2023 | 546.98 Mn |
| Mar 31, 2023 | 567.38 Mn |
| Dec 31, 2022 | 587.68 Mn |
| Sep 30, 2022 | 771.45 Mn |
| Jun 30, 2022 | 783.62 Mn |
| Mar 31, 2022 | 763.75 Mn |
| Dec 31, 2021 | 755.55 Mn |
| Sep 30, 2021 | 712.28 Mn |
| Mar 31, 2021 | 710.38 Mn |